• Bristol Myers Squibb average return on tangible equity for 2023 was -34.42, a 46.22% decline from 2022.
• Bristol Myers Squibb average return on tangible equity for 2022 was -23.54, a 425.59% increase from 2021.
• Bristol Myers Squibb average return on tangible equity for 2021 was 7.23, a 24.23% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.